Drugs / RG-7256
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01143753 | Jul 2010 → Jun 2012 | neoplasm | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG-7256 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545080 ↗ |
| Known as | PLX-3603 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545080 ↗ |
| Known as | RO5212054 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01143753 ↗ |
| Action | Inhibit | “the Selective BRAF Inhibitor RO5212054 (PLX3603)” NCT01143753 ↗ |
| Target | BRAF | “the Selective BRAF Inhibitor RO5212054 (PLX3603)” NCT01143753 ↗ |